OMP-18R5 Uses, Dosage, Side Effects and more
OMP-18R5 has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.
| Trade Name | OMP-18R5 |
| Generic | Vantictumab |
| Vantictumab Other Names | OMP-18R5, Vantictumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
